- Home
- GDHG vs NLSP Comparison
GDHG vs NLSP Comparison
Compare GDHG & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- NLSP
- Stock Information
- Founded
- GDHG 2008
- NLSP 2015
- Country
- GDHG China
- NLSP Switzerland
- Employees
- GDHG N/A
- NLSP N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- GDHG Consumer Discretionary
- NLSP Health Care
- Exchange
- GDHG Nasdaq
- NLSP Nasdaq
- Market Cap
- GDHG 23.6M
- NLSP 243.8M
- IPO Year
- GDHG 2023
- NLSP 2021
- Fundamental
- Price
- GDHG $2.53
- NLSP $4.55
- Analyst Decision
- GDHG
- NLSP
- Analyst Count
- GDHG 0
- NLSP 0
- Target Price
- GDHG N/A
- NLSP N/A
- AVG Volume (30 Days)
- GDHG 212.9K
- NLSP 33.1K
- Earning Date
- GDHG 07-30-2024
- NLSP 11-01-2024
- Dividend Yield
- GDHG N/A
- NLSP N/A
- EPS Growth
- GDHG N/A
- NLSP N/A
- EPS
- GDHG 1.62
- NLSP N/A
- Revenue
- GDHG $25,549,903.00
- NLSP N/A
- Revenue This Year
- GDHG N/A
- NLSP N/A
- Revenue Next Year
- GDHG N/A
- NLSP N/A
- P/E Ratio
- GDHG $1.61
- NLSP N/A
- Revenue Growth
- GDHG N/A
- NLSP N/A
- 52 Week Low
- GDHG $1.90
- NLSP $4.08
- 52 Week High
- GDHG $1,249.50
- NLSP $29.84
- Technical
- Relative Strength Index (RSI)
- GDHG 33.93
- NLSP 40.59
- Support Level
- GDHG $2.23
- NLSP $4.38
- Resistance Level
- GDHG $2.90
- NLSP $5.64
- Average True Range (ATR)
- GDHG 0.31
- NLSP 0.47
- MACD
- GDHG 0.14
- NLSP 0.06
- Stochastic Oscillator
- GDHG 62.50
- NLSP 29.16
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.